Turning foes to friends: Advanced " in situ nanovaccine" with dual immunoregulation for enhanced immunotherapy of metastatic triple-negative breast cancer
Ze Wang,Tong Sha,Jinwei Li,Huanyu Luo,Annan Liu,Hao Liang,Jinbiao Qiang,Lei Li,Andrew K. Whittaker,Bai Yang,Hongchen Sun,Ce Shi,Quan Lin
DOI: https://doi.org/10.1016/j.bioactmat.2024.04.023
IF: 18.9
2024-06-01
Bioactive Materials
Abstract:Highlights • Enhancing the immunogenicity and reversing the immunosuppressive microenvironment of TNBC remain a formidable challenge. • An " in situ nanovaccine" for imaging-guided PTT/CDT synergistic therapy to exert dual immunoregulatory effects on TNBC. • Through dual immunoregulation, "cold tumor" was transformed into a "hot tumor", enhancing immunotherapy against TNBC. • Au/CuNDs-R848 acted as an excellent nanoprobe, enabling near-infrared FL/CT imaging for precise visualization of TNBC. As a "cold tumor", triple-negative breast cancer (TNBC) exhibits limited responsiveness to current immunotherapy. How to enhance the immunogenicity and reverse the immunosuppressive microenvironment of TNBC remain a formidable challenge. Herein, an " in situ nanovaccine" Au/CuNDs-R848 was designed for imaging-guided photothermal therapy (PTT)/chemodynamic therapy (CDT) synergistic therapy to trigger dual immunoregulatory effects on TNBC. On the one hand, Au/CuNDs-R848 served as a promising photothermal agent and nanozyme, achieving PTT and photothermal-enhanced CDT against the primary tumor of TNBC. Meanwhile, the released antigens and damage-associated molecular patterns (DAMPs) promoted the maturation of dendritic cells (DCs) and facilitated the infiltration of T lymphocytes. Thus, Au/CuNDs-R848 played a role as an " in situ nanovaccine" to enhance the immunogenicity of TNBC by inducing immunogenic cell death (ICD). On the other hand, the nanovaccine suppressed the myeloid‐derived suppressor cells (MDSCs), thereby reversing the immunosuppressive microenvironment. Through the dual immunoregulation, "cold tumor" was transformed into a "hot tumor", not only implementing a "turning foes to friends" therapeutic strategy but also enhancing immunotherapy against metastatic TNBC. Furthermore, Au/CuNDs-R848 acted as an excellent nanoprobe, enabling high-resolution near-infrared fluorescence and computed tomography imaging for precise visualization of TNBC. This feature offers potential applications in clinical cancer detection and surgical guidance. Collectively, this work provides an effective strategy for enhancing immune response and offers novel insights into the potential clinical applications for tumor immunotherapy. Graphical abstract Download : Download high-res image (361KB) Download : Download full-size image
engineering, biomedical,materials science, biomaterials